These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37958995)

  • 1. Persistent Hypogammaglobulinemia after Receiving Rituximab Post-HSCT Is Not Caused by an Intrinsic B Cell Defect.
    Ott de Bruin LM; Pico-Knijnenburg I; van Ostaijen-Ten Dam MM; Weitering TJ; Berghuis D; Bredius RGM; Lankester AC; van der Burg M
    Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case Report: Persistent Hypogammaglobulinemia More Than 10 Years After Rituximab Given Post-HSCT.
    Luterbacher F; Bernard F; Baleydier F; Ranza E; Jandus P; Blanchard-Rohner G
    Front Immunol; 2021; 12():773853. PubMed ID: 35003091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case report: Persistent hypogammaglobulinemia and mixed chimerism after HLA class-II disparate-hematopoietic stem cell transplant.
    de Gier M; Pico-Knijnenburg I; van Ostaijen-Ten Dam MM; Berghuis D; Smiers FJ; van Beek AA; Jolink H; Jansen PM; Lankester AC; van der Burg M
    Front Immunol; 2024; 15():1397567. PubMed ID: 39044816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent hypogammaglobulinemia due to immunoglobulin class switch impairment by peri-transplant rituximab therapy.
    Mizuhara K; Fujii N; Meguri Y; Takahashi T; Aoe M; Nakamura M; Seike K; Sando Y; Fujii K; Abe M; Sumii Y; Urata T; Fujiwara Y; Saeki K; Asada N; Ennishi D; Nishimori H; Matsuoka KI; Maeda Y
    Int J Hematol; 2020 Sep; 112(3):422-426. PubMed ID: 32342335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypogammaglobulinemia in Children After Hematopoietic Stem Cell Transplantation and Rituximab Treatment: Relevance of B Cell Subsets.
    Marzollo A; Serena T; Mainardi C; Calore E; Pillon M; Carraro E; Tosato F; Biffi A; Tumino M
    J Pediatr Hematol Oncol; 2023 Jan; 45(1):e145-e149. PubMed ID: 36598967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-Hematopoietic Stem Cell Transplantation Rituximab for Epstein-Barr Virus and Post-Lymphoproliferative Disorder Prophylaxis in Alemtuzumab Recipients.
    Patel C; Pasciolla M; Abramova R; Salerno D; Gomez-Arteaga A; Shore TB; Orfali N; Mayer S; Hsu J; Phillips AA; Chaekal OK; Satlin MJ; Soave R; Kodiyanplakkal RPL; Drelick A; Plate M; Besien KV
    Transplant Cell Ther; 2023 Feb; 29(2):132.e1-132.e5. PubMed ID: 36334653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Rituximab and hypogammaglobulinemia].
    Fernández Romero DS; Torre MG; Larrauri BJ; Malbrán E; Juri MC; Malbrán A
    Medicina (B Aires); 2015; 75(5):319-23. PubMed ID: 26502469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rituximab Unveils Hypogammaglobulinemia and Immunodeficiency in Children with Autoimmune Cytopenia.
    Ottaviano G; Marinoni M; Graziani S; Sibson K; Barzaghi F; Bertolini P; Chini L; Corti P; Cancrini C; D'Alba I; Gabelli M; Gallo V; Giancotta C; Giordano P; Lassandro G; Martire B; Angarano R; Mastrodicasa E; Bava C; Miano M; Naviglio S; Verzegnassi F; Saracco P; Trizzino A; Biondi A; Pignata C; Moschese V
    J Allergy Clin Immunol Pract; 2020 Jan; 8(1):273-282. PubMed ID: 31377437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humoral Immune Reconstitution Kinetics after Allogeneic Hematopoietic Stem Cell Transplantation in Children: A Maturation Block of IgM Memory B Cells May Lead to Impaired Antibody Immune Reconstitution.
    Abdel-Azim H; Elshoury A; Mahadeo KM; Parkman R; Kapoor N
    Biol Blood Marrow Transplant; 2017 Sep; 23(9):1437-1446. PubMed ID: 28495643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypogammaglobulinemia and bacterial infections following pediatric post-transplant lymphoproliferative disorder in the rituximab era.
    Chiou FK; Beath SV; Patel M; Gupte GL
    Pediatr Transplant; 2019 Sep; 23(6):e13519. PubMed ID: 31209964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoglobulin serum levels in rituximab-treated patients with steroid-dependent nephrotic syndrome.
    Parmentier C; Delbet JD; Decramer S; Boyer O; Hogan J; Ulinski T
    Pediatr Nephrol; 2020 Mar; 35(3):455-462. PubMed ID: 31705306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Donor-Host Lineage-Specific Chimerism Monitoring and Analysis in Pediatric Patients Following Allogeneic Stem Cell Transplantation: Influence of Pretransplantation Variables and Correlation with Post-Transplantation Outcomes.
    Llaurador G; Nicoletti E; Prockop SE; Hsu S; Fuller K; Mauguen A; O'Reilly RJ; Boelens JJ; Boulad F
    Transplant Cell Ther; 2021 Sep; 27(9):780.e1-780.e14. PubMed ID: 34082161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting Severe Infection and Effects of Hypogammaglobulinemia During Therapy With Rituximab in Rheumatic and Musculoskeletal Diseases.
    Md Yusof MY; Vital EM; McElvenny DM; Hensor EMA; Das S; Dass S; Rawstron AC; Buch MH; Emery P; Savic S
    Arthritis Rheumatol; 2019 Nov; 71(11):1812-1823. PubMed ID: 31131994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypogammaglobulinemia in children after allogeneic hematopoietic stem cell transplantation: a cytokine mediated immunoglobulin isotype class switch arrest?
    Sundin M; Remberger M; Lindqvist H; Omazic B; Sundberg B; Uzunel M; Winiarski J
    Pediatr Blood Cancer; 2015 May; 62(5):890-6. PubMed ID: 25623620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical Analysis of Post-Transplant Lymphoproliferative Disorder after Hematopoietic Stem Cell Transplantation in Severe Aplastic Anemia Patients].
    Yan HM; Zheng XL; Zhu L; Ding L; Han DM; Liu J; Xue M; Li S; Wang HX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Aug; 30(4):1224-1229. PubMed ID: 35981389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profound symptomatic hypogammaglobulinemia: a rare late complication after rituximab treatment for immune thrombocytopenia. Report of 3 cases and systematic review of the literature.
    Levy R; Mahévas M; Galicier L; Boutboul D; Moroch J; Loustau V; Guillaud C; Languille L; Fain O; Bierling P; Khellaf M; Michel M; Oksenhendler E; Godeau B
    Autoimmun Rev; 2014 Oct; 13(10):1055-63. PubMed ID: 25183241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab Associated Hypogammaglobulinemia in Autoimmune Disease.
    Tieu J; Smith RM; Gopaluni S; Kumararatne DS; McClure M; Manson A; Houghton S; Jayne DRW
    Front Immunol; 2021; 12():671503. PubMed ID: 34054846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rituximab-induced hypogammaglobulinemia and infection risk in pediatric patients.
    Labrosse R; Barmettler S; Derfalvi B; Blincoe A; Cros G; Lacombe-Barrios J; Barsalou J; Yang N; Alrumayyan N; Sinclair J; Ong MS; Camargo CA; Walter J; Haddad E
    J Allergy Clin Immunol; 2021 Aug; 148(2):523-532.e8. PubMed ID: 33862010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and serological characterization of autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation.
    Yang Z; Wu B; Zhou Y; Wang W; Chen S; Sun A; Wu D; Xu Y
    Chin Med J (Engl); 2014; 127(7):1235-8. PubMed ID: 24709172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B-cell differentiation and IL-21 response in
    Miggelbrink AM; Logan BR; Buckley RH; Parrott RE; Dvorak CC; Kapoor N; Abdel-Azim H; Prockop SE; Shyr D; Decaluwe H; Hanson IC; Gillio A; Dávila Saldaña BJ; Eibel H; Hopkins G; Walter JE; Whangbo JS; Kohn DB; Puck JM; Cowan MJ; Griffith LM; Haddad E; O'Reilly RJ; Notarangelo LD; Pai SY
    Blood; 2018 Jun; 131(26):2967-2977. PubMed ID: 29728406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.